Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents-Reference-Cited by-同舟云学术

Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents

Published:2020-04 Issue:4 Volume:10 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer J.

Author:

Mina Roberto^ORCID,Joseph Nisha S.,Gay Francesca^ORCID,Kastritis Efstathios^ORCID,Petrucci Maria Teresa,Kaufman Jonathan L.^ORCID,Montefusco Vittorio,Gavriatopoulou Maria,Patriarca Francesca,Omedé Paola,Boise Lawrence H.^ORCID,Roussou Maria,Giuliani Nicola,Oliva Stefania,Offidani Massimo,Belotti Angelo,Jaye David L.,De Paoli Lorenzo,Terpos Evangelos^ORCID,Lonial Sagar,Boccadoro Mario,Nooka Ajay K.^ORCID,Dimopoulos Meletios A.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/s41408-020-0307-4.pdf

Reference15 articles.

1. Fonseca, R. et al. Clinical and biologic implications of recurrent genomic aberrations in myeloma. Blood 101, 4569–4575 (2003).

2. Boyd, K. D. et al. A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial. Leukemia 26, 349–355 (2012).

3. Lakshman, A. et al. Natural history of t(11;14) multiple myeloma. Leukemia 32, 131–138 (2018).

4. Chng, W. J. et al. IMWG consensus on risk stratification in multiple myeloma. Leukemia 28, 269–277 (2014).

5. Palumbo, A. et al. Revised international staging system for multiple myeloma: a report from international myeloma working group. J. Clin. Oncol. 33, 2863–2869 (2015).

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Still high risk? A review of translocation t(14;16) in multiple myeloma;American Journal of Hematology;2024-06-14

2. High‐risk multiple myeloma: Redefining genetic, clinical, and functional high‐risk disease in the era of molecular medicine and immunotherapy;American Journal of Hematology;2024-04-13

3. Megalosplenia as an initial manifestation of multiple myeloma with a novel CYLD gene mutation: A case report and literature review;Medicine;2024-04-05

4. Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation;British Journal of Haematology;2024-03-06

5. MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities;Haematologica;2024-01-18